Neurostatus-SMARTCARE clinical trial: Enabling health care professionals to assess EDSS for decentralized trials in multiple sclerosis

Neurostatus-SMARTCARE 临床试验:使医疗保健专业人员能够评估多发性硬化症分散试验中的 EDSS 评分

阅读:1

Abstract

BACKGROUND: Neurostatus-Expanded Disability Status Scale (EDSS) is the standard measure used to assess impairment and disability in multiple sclerosis (MS) trials but requires trained expert neurologists. OBJECTIVES: This study aims to evaluate the concordance of Neurostatus-EDSS assessments from specially trained health care professionals (HCPs) and standardized trained neurologists. METHODS: A Swiss multicenter, randomized, cross-over study with 100 people with MS. HCPs were trained to assess the Neurostatus-EDSS based on the newly developed SMARTCARE-EDSS training method. RESULTS: The concordance rate between HCPs and neurologists was 0.87 (95% confidence interval (CI) = 0.815-0.925). CONCLUSION: Trained HCPs can reliably perform Neurostatus-EDSS assessments, supporting broader implementation and improved trial access.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。